Ken Griffin's position in Editas Medicine is currently worth $895 Thousand. That's 0.00% of their equity portfolio (2874th largest holding). The first Editas Medicine trade was made in Q1 2017. Since then Ken Griffin bought shares 43 more times and sold shares on 35 occasions. The investor's estimated purchase price is $5.67 Million, resulting in a loss of 84%.